Search for Clinical Trial Results

Sponsored By

Aggressive NK Cell Leukemia - 24 Studies Found

Status Study
Terminated Study Name: Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte Leukemia
Condition:
  • Large Granular Lymphocytic Leukemia
  • LGL L
    Date: 2006-08-10
    Interventions:
    • Drug: Cyclosporine An oral pre
Terminated Study Name: Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia
Condition: T-Cell Large Granular Lymphocytic Leukemia
Date: 2006-01-16
Interventions: Drug: MTX followed by fludarabine MTX should be administered with 10-20mg weekly, calculated according t
Recruiting Study Name: Prospective, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (Methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia
Condition: Large Granular Lymphocytes Leukemia
Date: 2013-10-22
Interventions:
  • Drug: Methotrexate methotrexat
Completed Study Name: Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia
Condition:
  • T-Cell Large Granular Lymphocytic Leukemia
  • Leukemia, T-Cell Lar
    Date: 2004-01-14
    Interventions: Biological: Hu-MiK-Beta-1 Hu-MiK-Beta-1 administered as an intravenous infusion over 90- minutes.
Terminated Study Name: Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte Leukemia
Condition:
  • Stage III Chronic Lymphocytic Leukemia
  • Stage IV Chronic Lymphocytic Leukemia
  • Date: 2006-08-03
    Interventions:
    • Drug: tipifarnib Given orally
Terminated Study Name: Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)
Condition: Leukemia
Date: 2010-08-27
Interventions: Drug: Alemtuzumab 10 mg by vein over 2 hours on Days 1 to 10 of a 28 day cycle.
Completed Study Name: Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia
Condition: Leukemia
Date: 2001-07-11
Interventions: Biological: monoclonal antibody Mik-beta-1
Recruiting Study Name: Alemtuzumab (Campath ) to Treat T-Large Granular Lymphocyte Leukemia
Condition: Lymphoproliferative Disorders
Date: 2006-06-27
Interventions: Drug: Alemtuzumab (Campath)
Completed Study Name: Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
Condition:
  • Anemia
  • Leukemia
  • Neutropenia
  • CLL
  • SLL
  • HCL
  • Richter´
    Date: 2015-02-26
Next >>>